Kezar Life Sciences
ID: 5313028Kezar Life Sciences is a therapies for autoimmune disorders founded in 2015 by John Fowler.
2
Funding Rounds
$100.0m
Money raised
Recent Funding Rounds
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Ch********* Ki** | - | - | - |
| Name | Phone | Social networks | |
|---|---|---|---|
| Ch********* Ki** | - | - | - |
| Mi*** Kl****** | - | - | - |
| El******* Ga**** | - | - | - |
| Co****** Wa***** | - | - | - |
| Mi***** Ka****** | - | - | - |
| Fr****** M. Be**** | - | - | |
| Gr**** Co**** | - | - |
Funding series
Funding Series Analysis
The company Kezar Life Sciences has raised a total of $50m in funding over 2 rounds.
Key Insights:
- Kezar Life Sciences Series B round, July 2017: $50m
- Kezar Life Sciences funding round, July 2017: $50m
Industries
Kezar Life Sciences is active in the following industries: